期刊文献+

苯磺酸氨氯地平口腔崩解片的工艺优选与含量测定 被引量:7

Preparation and quality control of amlodipine besylate oral rapidly disintegrating tablets
原文传递
导出
摘要 目的:优选苯磺酸氨氯地平口腔崩解片最佳制备工艺,并建立其含量测定方法。方法:以口感、崩解时限及溶出度为参数,采用正交设计法优化包衣颗粒与片芯处方,并采用HPLC法测定所制备样品的含量。结果:最佳处方为苯磺酸氨氯地平原料5.0g,甘露醇160g,聚维酮K301.0g,乙基纤维素20g,交联聚乙烯吡咯烷酮6.0g,阿斯巴甜2.0g,微粉硅胶2.0g,香橙香精2g,硬脂酸镁2g(制成1000片)。苯磺酸氨氯地平进样量(μg)在0.2036~2.036μg范围内与峰面积线性关系良好。平均回收率为99.16%,RSD为0.45%(n=9)。结论:处方设计合理,测定方法操作方便,结果准确,重复性好。 OBJECTIVE To study the formula optimization and the content determination of amlodipine besylate oral disinte grating tablets. METHODS Based on the taste, disintegration time and dissolution of the product, to sieve the optimal formula and preparation procedure. The quantitative determination of amlodipine besylate was performed with HPI.C method. RESULTS The optimal formula was as follows: amlodipine besylate 5.0 g, mannitol 160 g, povidone k30 1.0 g, ethyl cellulose 20 g, pvpp 6.0 g, aspartame 2.0 g, SiO22. 0 g, orange essence 2. 0 g, magnesium stearate 2. 0 g. The standard curve was linear over the filling quantity range of 0. 203 6-2.036 g for amlodipine besylate. The precision and reappearance were good. The recov- ery rate of amlodipine besylate was 99. 16% with RSD 0. 45% (n = 9). CONCLUSION The methods of identification, check and quantitative determination are simple, accurate, reproducible and highly selective.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2010年第3期206-210,共5页 Chinese Journal of Hospital Pharmacy
关键词 苯磺酸氨氯地平 口腔崩解片 正交试验 崩解时限 含量测定 amlodipine besylate oral rapidly disintegrating tablets orthogonal design disintegration time content determina-tion
  • 相关文献

参考文献6

二级参考文献31

  • 1龙晓英,杨帆,陈立豪,曹灼林.布洛芬口腔崩解片的制备及质量检查[J].中国医药工业杂志,2004,35(7):407-409. 被引量:14
  • 2戴玉华.团结起来 为防治高血压做出更大努力[J].中华全科医师杂志,2005,4(1):1-2. 被引量:6
  • 3孙宁云,吴伟.口腔崩解片的研究进展[J].中国医药工业杂志,2005,36(12):784-788. 被引量:11
  • 4尚飞,尚奎洪.氨氯地平片剂的HPLC测定[J].中国医药工业杂志,1996,27(9):411-413. 被引量:5
  • 5Seager H. Drug-delivery products and the Zydis fast-dissolving dosage form[J]. J Pharm Pharmcol, 1998, 50 (4) : 375-382.
  • 6Sam C, Jean PR. Formulation and production of rapidly disintegrating tablets by lyophilization using hydrochlorothiazide as a model drug [J]. Int J Pharm, 1997, 152 (2):215-225.
  • 7Gole DJ, Levinson RS, Carbone J, et al. Preparation of pharmaceutical and other matrix system by solid-state dissolution[P]. US: 5215756, 1993-06-01. (CA 1993, 115: 120088).
  • 8Allen LV, Wang BN, Davies JD. Rapidly dissolving oral dosage form[P]. WO: 9520377, 1995-08-03. (CA 1995, 123:208904).
  • 9Ishikawa T, Mukai B, Shiraishi S, et al. Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted-hydroxypropylcellulose or spherical sugar granules by direct compression method[J].Chem Pharm Bull (Tokyo), 2001, 49 (2) : 134-139.
  • 10Abdelbary G, Prinderre P, Eouani C, et al. The preparation of orally disintegrating tablets using a hydrophilic waxy binder[J]. Int J Pharm, 2004, 278 (2) : 423-433.

共引文献177

同被引文献94

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部